Type 2 diabetes

Dec 11, 2018

Axovant tips nelotanserin from small molecule R&D Axovant has stopped nelotanserin development after it missed the primary endpoint in a phase 2 trial in patients with Lewy body dementia. The dull data compelled Axovant to miss the drug and finish its pivot from small molecules to gene therapies. The parent comp...

Nov 14, 2018

[caption id="attachment_3594" align="aligncenter" width="1360"] World Diabetes Day[/caption] Today we celebrate World Diabetes Day to raise global awareness of a disease that affects million people worldwide. In honor of this day, we have garnered myths & facts about diabetes.

Nov 14, 2018

[caption id="attachment_3575" align="aligncenter" width="1360"] World Diabetes Day[/caption] Caring for Diabetes involves family too. Education and awareness play the most important role in early diagnosis and management. World Diabetes Day is celebrated on 14 November each year.

Oct 23, 2018

Novartis comes up with an answer for breast cancer with PI3K drug alpelisib Novartis comes up with an answer with its recent data on BYL719 (alpelisib) in combination with fulvestrant. Their alpha-specific drug for PIK3CA mutated HR+/HER2- advanced breast cancer, BYL719 plus fulvestrant nearly doubled the progressio...